Immediate Action Needed: Drug Development Pipeline at Risk We are currently experiencing a crisis in which 60% of the preclinical non-human primate models critical to this work are being denied permits by the U.S. Fish and Wildlife Service. This disruption will significantly slow the U.S. biopharmaceutical pipeline, stifle scientific advancement, impair research, halt industry-wide economic growth, and deprive patients of potentially life-saving treatments. The gravity of this situation cannot be understated. A sustainable solution to this critical issue is urgently needed for all stakeholders.
- Take Action
- Immediate Action Needed: Drug Development Pipeline at Risk